1. Home
  2. AWRE vs NSRX Comparison

AWRE vs NSRX Comparison

Compare AWRE & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$1.28

Market Cap

28.1M

Sector

Technology

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$2.84

Market Cap

25.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
NSRX
Founded
1986
2019
Country
United States
Israel
Employees
N/A
7
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.1M
25.8M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AWRE
NSRX
Price
$1.28
$2.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
51.0K
125.1K
Earning Date
04-29-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.98
52 Week High
$2.95
$9.99

Technical Indicators

Market Signals
Indicator
AWRE
NSRX
Relative Strength Index (RSI) 48.96 46.96
Support Level $1.09 $2.04
Resistance Level $1.39 $3.48
Average True Range (ATR) 0.13 0.30
MACD 0.00 0.01
Stochastic Oscillator 46.30 39.25

Price Performance

Historical Comparison
AWRE
NSRX

About AWRE Aware Inc.

Aware Inc provides biometric identity and authentication solutions. Its Awareness Platform transforms biometric data into actionable intelligence, allowing its clients to verify identities and authenticate access and transactions. The company's products span multiple biometric modalities, including fingerprint, face, iris, and voice. It offers: a broad range of biometrics software products and solutions, including platforms like AwareSDK, AwareABIS, AFIX Suite of Products, Awareness Platform, and WebEnroll; software components such as SDKs, APIs, and applications that customers use to develop their systems into more effective solutions; and several program management and software engineering services. Aware earns maximum revenue from the U.S., followed by the UK and the rest of the world.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: